Association of metabolic syndrome with Alzheimer disease: a population-based study
- PMID: 16966548
- DOI: 10.1212/01.wnl.0000234037.91185.99
Association of metabolic syndrome with Alzheimer disease: a population-based study
Abstract
Objective: To assess the association of metabolic syndrome (MetS) with Alzheimer disease (AD).
Methods: The authors derived subjects from a population-based study of 980 randomly selected elderly subjects. After exclusion of all non-Alzheimer dementia cases, the final study population included 959 subjects (337 men and 622 women) aged 69 to 78 years. The presence of MetS was defined according to the National Cholesterol Education Program (Adult Treatment Panel III) criteria, and the diagnosis of AD was based on the criteria of the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association.
Results: Of the study subjects, 418 (43.6%) had MetS. Probable or possible AD was diagnosed in 45 subjects (4.7%). AD was more frequently detected in subjects with MetS than in subjects without MetS (7.2 vs 2.8%; p < 0.001). The prevalence of AD was higher in women with MetS vs women without the syndrome (8.3 vs 1.9%; p < 0.001), but in men with MetS, the prevalence of AD was not increased (3.8 vs 3.9%; p = 0.994). In univariate logistic regression analysis, MetS was significantly associated with AD (odds ratio [OR] 2.71; 95% CI 1.44 to 5.10). In multivariate logistic regression analysis including also apolipoprotein E4 phenotype, education, age, and total cholesterol, MetS was significantly associated with AD (OR 2.46; 95% CI 1.27 to 4.78). If only nondiabetic subjects were included in the multivariate analysis, MetS was still significantly associated with AD (OR 3.26; 95% CI 1.45 to 7.27).
Conclusion: Metabolic syndrome is associated with Alzheimer disease in elderly subjects.
Similar articles
-
Metabolic syndrome and risk of dementia in older adults.J Am Geriatr Soc. 2010 Mar;58(3):487-92. doi: 10.1111/j.1532-5415.2010.02731.x. J Am Geriatr Soc. 2010. PMID: 20398117
-
Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data.Postgrad Med. 2009 Nov;121(6):9-20. doi: 10.3810/pgm.2009.11.2073. Postgrad Med. 2009. PMID: 19940413
-
The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women.Climacteric. 2007 Apr;10(2):164-70. doi: 10.1080/13697130701258895. Climacteric. 2007. PMID: 17453865
-
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.Ageing Res Rev. 2010 Oct;9(4):399-417. doi: 10.1016/j.arr.2010.04.007. Epub 2010 May 2. Ageing Res Rev. 2010. PMID: 20444434 Review.
-
Clinical diagnosis and management of Alzheimer's disease.Neuroimaging Clin N Am. 2005 Nov;15(4):767-77, ix-x. doi: 10.1016/j.nic.2005.09.005. Neuroimaging Clin N Am. 2005. PMID: 16443489 Review.
Cited by
-
Effects of MIND diet and propolis supplementation on metabolic syndrome indices and cognitive function among patients with metabolic syndrome in Isfahan, Iran, 2024. A rationale and study protocol for randomized controlled trial.Health Sci Rep. 2024 Aug 12;7(8):e2262. doi: 10.1002/hsr2.2262. eCollection 2024 Aug. Health Sci Rep. 2024. PMID: 39135701 Free PMC article.
-
Anorexigenic neuropeptides as anti-obesity and neuroprotective agents: exploring the neuroprotective effects of anorexigenic neuropeptides.Biosci Rep. 2024 Apr 24;44(4):BSR20231385. doi: 10.1042/BSR20231385. Biosci Rep. 2024. PMID: 38577975 Free PMC article. Review.
-
Formulating Treatment to Cure Alzheimer's Dementia: Approach #2.Int J Mol Sci. 2024 Mar 20;25(6):3524. doi: 10.3390/ijms25063524. Int J Mol Sci. 2024. PMID: 38542495 Free PMC article. Review.
-
Upsetting the Balance: How Modifiable Risk Factors Contribute to the Progression of Alzheimer's Disease.Biomolecules. 2024 Feb 24;14(3):274. doi: 10.3390/biom14030274. Biomolecules. 2024. PMID: 38540695 Free PMC article. Review.
-
Investigating the nexus of metabolic syndrome, serum uric acid, and dementia risk: a prospective cohort study.BMC Med. 2024 Mar 13;22(1):115. doi: 10.1186/s12916-024-03302-5. BMC Med. 2024. PMID: 38481272 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical